Cargando…

Practical Synthesis of Cytidine-5-Carboxamide-Modified Nucleotide Reagents

Chemically-modified derivatives of cytidine, bearing a 5-(N-substituted-carboxamide) functional group, are new reagents for use in aptamer discovery via the SELEX process (Systematic Evolution of Ligands by EXponential enrichment). Herein, we disclose a practical synthesis of 5-(N-benzylcarboxamide)...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohloff, John C., Fowler, Catherine, Ream, Brian, Carter, Jeffrey D., Wardle, Greg, Fitzwater, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353258/
https://www.ncbi.nlm.nih.gov/pubmed/25710355
http://dx.doi.org/10.1080/15257770.2014.978011
_version_ 1782360582204162048
author Rohloff, John C.
Fowler, Catherine
Ream, Brian
Carter, Jeffrey D.
Wardle, Greg
Fitzwater, Tim
author_facet Rohloff, John C.
Fowler, Catherine
Ream, Brian
Carter, Jeffrey D.
Wardle, Greg
Fitzwater, Tim
author_sort Rohloff, John C.
collection PubMed
description Chemically-modified derivatives of cytidine, bearing a 5-(N-substituted-carboxamide) functional group, are new reagents for use in aptamer discovery via the SELEX process (Systematic Evolution of Ligands by EXponential enrichment). Herein, we disclose a practical synthesis of 5-(N-benzylcarboxamide)-2′-deoxycytidine, and the corresponding 5-(N-1-naphthylmethylcarboxamide)- and 5-(N-3-phenylpropylcarboxamide)-2′-deoxycytidine analogs, as both the suitably-protected 3′-O-cyanoethylphosphoramidite reagents (CEP; gram scale) and the 5′-O-triphosphate reagents (TPP; milligram-scale). The key step in the syntheses is a mild, palladium(0)-catalyzed carboxyamidation of an unprotected 5-iodo-cytidine. Use of the CEP reagents for solid-phase oligonucleotide synthesis was demonstrated and incorporation of the TPP reagents by KOD polymerase in a primer extension assay confirmed the utility of these reagents for SELEX. Finally, the carboxyamidation reaction was also used to prepare the nuclease-resistant sugar-variants: 5-(N-benzylcarboxamide)-2′-O-methyl-cytidine and 5-(N-3-phenylpropylcarboxamide)-2′-deoxy-2′-fluoro-cytidine.
format Online
Article
Text
id pubmed-4353258
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-43532582015-03-23 Practical Synthesis of Cytidine-5-Carboxamide-Modified Nucleotide Reagents Rohloff, John C. Fowler, Catherine Ream, Brian Carter, Jeffrey D. Wardle, Greg Fitzwater, Tim Nucleosides Nucleotides Nucleic Acids Original Articles Chemically-modified derivatives of cytidine, bearing a 5-(N-substituted-carboxamide) functional group, are new reagents for use in aptamer discovery via the SELEX process (Systematic Evolution of Ligands by EXponential enrichment). Herein, we disclose a practical synthesis of 5-(N-benzylcarboxamide)-2′-deoxycytidine, and the corresponding 5-(N-1-naphthylmethylcarboxamide)- and 5-(N-3-phenylpropylcarboxamide)-2′-deoxycytidine analogs, as both the suitably-protected 3′-O-cyanoethylphosphoramidite reagents (CEP; gram scale) and the 5′-O-triphosphate reagents (TPP; milligram-scale). The key step in the syntheses is a mild, palladium(0)-catalyzed carboxyamidation of an unprotected 5-iodo-cytidine. Use of the CEP reagents for solid-phase oligonucleotide synthesis was demonstrated and incorporation of the TPP reagents by KOD polymerase in a primer extension assay confirmed the utility of these reagents for SELEX. Finally, the carboxyamidation reaction was also used to prepare the nuclease-resistant sugar-variants: 5-(N-benzylcarboxamide)-2′-O-methyl-cytidine and 5-(N-3-phenylpropylcarboxamide)-2′-deoxy-2′-fluoro-cytidine. Taylor & Francis 2015-03-04 2015-02-24 /pmc/articles/PMC4353258/ /pubmed/25710355 http://dx.doi.org/10.1080/15257770.2014.978011 Text en © 2015 Specialty Chemistry. Published with license by Taylor & Francis This is an Open Access article. Non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly attributed, cited, and is not altered, transformed, or built upon in any way, is permitted. The moral rights of the named author(s) have been asserted.
spellingShingle Original Articles
Rohloff, John C.
Fowler, Catherine
Ream, Brian
Carter, Jeffrey D.
Wardle, Greg
Fitzwater, Tim
Practical Synthesis of Cytidine-5-Carboxamide-Modified Nucleotide Reagents
title Practical Synthesis of Cytidine-5-Carboxamide-Modified Nucleotide Reagents
title_full Practical Synthesis of Cytidine-5-Carboxamide-Modified Nucleotide Reagents
title_fullStr Practical Synthesis of Cytidine-5-Carboxamide-Modified Nucleotide Reagents
title_full_unstemmed Practical Synthesis of Cytidine-5-Carboxamide-Modified Nucleotide Reagents
title_short Practical Synthesis of Cytidine-5-Carboxamide-Modified Nucleotide Reagents
title_sort practical synthesis of cytidine-5-carboxamide-modified nucleotide reagents
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353258/
https://www.ncbi.nlm.nih.gov/pubmed/25710355
http://dx.doi.org/10.1080/15257770.2014.978011
work_keys_str_mv AT rohloffjohnc practicalsynthesisofcytidine5carboxamidemodifiednucleotidereagents
AT fowlercatherine practicalsynthesisofcytidine5carboxamidemodifiednucleotidereagents
AT reambrian practicalsynthesisofcytidine5carboxamidemodifiednucleotidereagents
AT carterjeffreyd practicalsynthesisofcytidine5carboxamidemodifiednucleotidereagents
AT wardlegreg practicalsynthesisofcytidine5carboxamidemodifiednucleotidereagents
AT fitzwatertim practicalsynthesisofcytidine5carboxamidemodifiednucleotidereagents